DSIP addresses the sleep disruption that compounds nearly every other symptom
Thus, patients taking the agents associated with the greatest weight loss, tirzepatide and semaglutide, have the highest incidence of developing both hypocalcemia and hypercalcemia
Diabetologia 60, 15661576
dermatologist 57: 1143-1153 Tio D et al (2018) Variation in the diagnosis and clinical management of lentigo maligna acrossEurope : a survey study among European Association of Dermatologists andVenereologists members.J Eur Acad Dermatol Venereol 32:1476-1484

Sources Glucagon-Like Peptide-1 Receptor Agonists, PubMed [accessed 16 October 2024] Ozempic 0.5 mg solution for injection in pre-filled pen SmPC, emc [accessed 16 October 2024] Saxenda 6 mg/mL solution for injection in pre-filled pen SmPC, emc [accessed 16 October 2024] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, NEJM [accessed 16 October 2024] Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials, PubMed [accessed 16 October 2024] Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial, The Lancet [accessed 16 October 2024] Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen SmPC, emc [accessed 16 October 2024] Once-Weekly Semaglutide in Adults with Overweight or Obesity, NEJM [accessed 16 October 2024] Patient Reviews Related Weight Loss Treatments Further Reading on Weight Loss Do Appetite Suppressants Work
